These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24120346)

  • 1. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.
    Shahinian H; Loessner D; Biniossek ML; Kizhakkedathu JN; Clements JA; Magdolen V; Schilling O
    Mol Oncol; 2014 Feb; 8(1):68-82. PubMed ID: 24120346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.
    Loessner D; Quent VM; Kraemer J; Weber EC; Hutmacher DW; Magdolen V; Clements JA
    Gynecol Oncol; 2012 Dec; 127(3):569-78. PubMed ID: 22964375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
    Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
    Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.
    Silva LM; Kryza T; Stoll T; Hoogland C; Dong Y; Stephens CR; Hastie ML; Magdolen V; Kleifeld O; Gorman JJ; Clements JA
    Mol Cell Proteomics; 2019 May; 18(5):818-836. PubMed ID: 30705123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
    Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
    Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
    Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
    Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.
    Prezas P; Arlt MJ; Viktorov P; Soosaipillai A; Holzscheiter L; Schmitt M; Talieri M; Diamandis EP; Krüger A; Magdolen V
    Biol Chem; 2006 Jun; 387(6):807-11. PubMed ID: 16800744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
    Gong W; Liu Y; Seidl C; Dreyer T; Drecoll E; Kotzsch M; Bronger H; Dorn J; Magdolen V
    PLoS One; 2019; 14(2):e0212968. PubMed ID: 30811511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
    Obiezu CV; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Rigault de la Longrais IA; Arisio R; Diamandis EP
    Clin Cancer Res; 2001 Aug; 7(8):2380-6. PubMed ID: 11489816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.
    Dong Y; Stephens C; Walpole C; Swedberg JE; Boyle GM; Parsons PG; McGuckin MA; Harris JM; Clements JA
    PLoS One; 2013; 8(2):e57056. PubMed ID: 23451143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA (hsa_circ_0051240) promotes cell proliferation, migration and invasion in ovarian cancer through miR-637/KLK4 axis.
    Zhang M; Xia B; Xu Y; Zhang Y; Xu J; Lou G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1224-1233. PubMed ID: 30945557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
    Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA
    Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones.
    Korkmaz KS; Korkmaz CG; Pretlow TG; Saatcioglu F
    DNA Cell Biol; 2001 Jul; 20(7):435-45. PubMed ID: 11506707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
    Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
    Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.
    Reid JC; Matsika A; Davies CM; He Y; Broomfield A; Bennett NC; Magdolen V; Srinivasan B; Clements JA; Hooper JD
    Am J Cancer Res; 2017; 7(11):2257-2274. PubMed ID: 29218249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
    Oikonomopoulou K; Scorilas A; Michael IP; Grass L; Soosaipillai A; Rosen B; Murphy J; Diamandis EP
    Tumour Biol; 2006; 27(2):104-14. PubMed ID: 16557045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma.
    Foteinou E; Kontos CK; Giotakis AI; Scorilas A
    Biol Chem; 2014 Sep; 395(9):1051-62. PubMed ID: 24854539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.
    Koczorowska MM; Tholen S; Bucher F; Lutz L; Kizhakkedathu JN; De Wever O; Wellner UF; Biniossek ML; Stahl A; Lassmann S; Schilling O
    Mol Oncol; 2016 Jan; 10(1):40-58. PubMed ID: 26304112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
    Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
    Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidase 4 contributes to the tumor metastasis of oral squamous cell carcinoma.
    Cui Z; Cui Y; Luo G; Yang S; Ling X; Lou Y; Sun X
    Biosci Biotechnol Biochem; 2017 Sep; 81(9):1768-1777. PubMed ID: 28743213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.